+629.1%
MRNA vs MET
+202.0%
+427.1%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | MET | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.2% | -3.6% | -3.4% |
| 7D | -10.1% | -0.8% | -9.3% | -10.0% |
| 30D | +126.7% | -1.4% | +128.1% | +126.9% |
| 3M | +184.1% | +12.5% | +171.6% | +176.1% |
| 6M | +143.3% | +37.1% | +106.2% | +126.5% |
| YTD | +359.9% | +23.8% | +336.1% | +336.5% |
| 1Y | +454.2% | +24.1% | +430.1% | +425.7% |
| 3Y | +26.0% | +65.2% | -39.2% | +14.2% |
| 5Y | -70.3% | +82.3% | -152.5% | -73.1% |
| All | +629.1% | +202.0% | +427.1% | +506.0% |
Cumulative growth
Daily Returns
Daily percentage return beside MET.
Daily Out/Under-Performance
Portfolio return minus MET return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MET return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded MET wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling